Literature DB >> 9600060

Prompt activation of telomerase by chemical carcinogens in rats detected with a modified TRAP assay.

M Miura1, Y Karasaki, T Abe, K Higashi, K Ikemura, S Gotoh.   

Abstract

The maintenance of telomere length is crucial for survival of cells. Telomerase is an RNA-containing reverse transcriptase, which is responsible for elongation of shortened telomeres. Telomerase reactivation has been suggested to be involved in malignant progressions. To study on the involvement of telomerase activation in in vivo carcinogenesis, we first modified the original TRAP assay by changing the primer designs and the labeling method of PCR products to an end-labeling method. Second, we investigated the activation of telomerase in different organs after treatments of rats with various chemical carcinogens. Very early after the beginning of the treatment, telomerase activity in the liver, kidney, and lung was increased. In most cases, telomerase activation occurred in the primary or favorite target organs. The present results suggest that telomerase activation occurs promptly when animals are exposed to chemical carcinogens, which may contribute to in vivo chemical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9600060     DOI: 10.1006/bbrc.1998.8487

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Increased hepatic telomerase activity in a rat model of iron overload: a role for altered thiol redox state?

Authors:  Kyle E Brown; M Meleah Mathahs; Kimberly A Broadhurst; Mitchell C Coleman; Lisa A Ridnour; Warren N Schmidt; Douglas R Spitz
Journal:  Free Radic Biol Med       Date:  2006-10-17       Impact factor: 7.376

2.  Telomerase is upregulated in irreversible preneoplastic lesions during bladder carcinogenesis in rats.

Authors:  Toru Shimazui; Yoshihiro Ami; Naoto Miyanaga; Yukitaka Ideyama; Takahito Nakahara; Hideyuki Akaza
Journal:  Jpn J Cancer Res       Date:  2002-05

3.  Combined treatment with emodin and a telomerase inhibitor induces significant telomere damage/dysfunction and cell death.

Authors:  Rui Liu; Jing Liu; Shuqing Wang; Yinsong Wang; Tao Zhang; Yang Liu; Xin Geng; Feng Wang
Journal:  Cell Death Dis       Date:  2019-07-11       Impact factor: 8.469

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.